Galectin-9 is increased in several hematologic neoplasia, including chronic lymphocytic leukemia [64], cutaneous T cell lymphoma, and acute myeloid leukemia (AML) [65]. This evidence concerns the gene LGALS9 and acute myeloid leukemia.